Jack was born with an eye condition known as retinitis pigmentosa associated with RPE65 gene mutations. On March 20, 2018, he was treated with a newly FDA-approved gene therapy drug known as Luxturna — and the results are life-changing.
Archive for Patient Stories
Diagnosed with a rare form of glaucoma at age 15, Alex LeClair reflects on her journey with the sight-stealing condition.
Tom Maholchic was just 25-years-old when a loud event brought on hyperacusis with pain, a debilitating condition in which everyday noises are agony.
CEO of Halen Brands and a trustee of Mass. Eye and Ear, Jason Cohen was diagnosed with tinnitus (ringing in the ears) after a bad fall while skiing. He relies on endless support from his family and his doctors, and hopes to help Mass. Eye and Ear make a difference one day.
When Katie Niemeyer was 16 years old, she had an extreme reaction to a new medication — leading to a diagnosis of Stevens Johnson Syndrome. Within days, she was hospitalized with second and third degree burns covering her entire body and given only a 50 percent chance to live. Today, she supports Mass. Eye and Ear research to tackle the devastating disease.
Will McNamara lines up for his 9th Boston Marathon as part of Team Eye and Ear, raising funds for research driven to bring his sight back.